Table 2.
Summary characteristics of analyzed population (N = 315)
| Participant characteristics | |
| Age (years) | 48 (16) |
| Female, n (%) | 166 (53) |
| Diabetes type, n (%) | |
| Type 1 | 272 (86) |
| Type 2 | 39 (12) |
| Other (including type 3c) | 4 (1) |
| Self-reported race and ethnicity, n (%) | |
| Asian, non-Hispanic | 8 (3) |
| Black, non-Hispanic | 12 (4) |
| White, Hispanic | 2 (0) |
| White, non-Hispanic | 279 (89) |
| None of the above | 14 (4) |
| Insurance type, n (%) | |
| Private | 244 (77) |
| Public | 68 (22) |
| None | 2 (1) |
| Unknown | 1 (0) |
| CGM periods with 90 days of monitoring and <10% data missing, n (%) | 958 (100) |
| CGM periods per individual, n (%) | |
| 1 | 135 (43) |
| 2 | 76 (24) |
| 3 | 39 (12) |
| ≥4 | 65 (21) |
| Laboratory test characteristics | |
| HbA1c (%) | 7.0 (1.0) |
| HbA1c (mmol/mol) | 53 (11) |
| eAGCGM (mg/dL) | 167 (28) |
| Derived characteristics | |
| eAGA1c (mg/dL) | 155 (28) |
| GMI (%) | 7.3 (0.7) |
| Mismatch eAGCGM-eAGA1c (mg/dL) | 12 (20) |
| Mismatch HbA1c-GMI (%) | −0.3 (0.7) |
| Missing CGM data, n (%) | |
| <1% | 12 (1) |
| 1–5% | 653 (68) |
| 6–10% | 293 (31) |
Data are means (SD) unless otherwise indicated. GMI, glucose management indicator (23).
CGM, continuous glucose monitoring.